Bigbear Pharmaceutical·Medication Guide

• Is it safe to continue using avatrombopag if it has expired or the outer packaging is damaged?

  If the product has expired, do not continue to use it.【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 141

• DOPTELET (avatrombopag) Drug Guide

  The U.S. Food and Drug Administration (FDA) has approved DOPTELET as a prescription drug for adult patients with thrombocytopenia due to long-term (ch···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 139

• FDA Accepts New Drug Application for Avatrombopag for the Treatment of Immune Thrombocytopenic Pulmo

  Sobi Pharma North America announced on December 12th (Eastern Time) that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 144

• RET kinase inhibitor Retevmo (selpercatinib) approved by FDA for treatment of three types of cancer

  The U.S. FDA recently approved Retevmo (selpercatinib, 40 mg and 80 mg capsules), a targeted anticancer drug from Eli Lilly subsidiary LoxoOncology, f···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 147

• FDA Accelerates Approval for Retevmo (selpercatinib) to Treat RET Mutation or Fusion-Related Cancers

  On May 8, 2020, the U.S. Food and Drug Administration (FDA) accelerated the approval of the oral kinase inhibitor Retevmo (selpercatinib; LillyOncolog···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 148

• The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Retevmo (selpercatin

  On September 21, 2022, Eli Lilly and Company announced that the FDA has granted accelerated approval to Retevmo (selpercatinib) for the treatment of a···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 160

• Eli Lilly's RET inhibitor Retevmo approved for children aged 2 years and older with RET-mutated

  According to a May 29th press release from the U.S. FDA, Retevmo (selpercatinib) from Eli Lilly is approved for the treatment of children aged 2 years···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 142

• Retevmo Receives Conventional Approval for RET Fusion-Positive Thyroid Cancer

  The U.S. FDA recently granted conventional approval to Eli Lilly's selective RET kinase inhibitor Retevmo (selpercatinib) for the treatment of adu···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 147

• Retevmo Receives Regular Approval from FDA for Treatment of RET-Mutant Medullary Thyroid Carcinoma

  According to Eli Lilly, the U.S. Food and Drug Administration (FDA) announced on September 27 that it has granted regular approval to the RET inhibito···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 144

• What is tucatinib

  Tucatinib is a type of targeted anticancer drug, which is used in combination with other medications for the treatment of advanced breast cancer.···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 134

• What happens if I miss a dose of tucatinib

  If you vomit or miss a dose of tucatinib, take your next dose at your regular time.【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 149

• How should I take tucatinib

  Take tucatinib exactly as your healthcare provider tells you.Tucatinib is used with the medicines trastuzumab and capecitabine. Your healthcare provid···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 140

• What's the mechanism of action for tucatinib

  Tucatinib (Tukysa) is a human epidermal growth factor receptor-2 (HER2) inhibitor that works by blocking the HER2 protein to help slow or stop ca···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 157

• FDA Approves Promacta as First-Line Therapy for Aplastic Anemia

  Overview of Severe Aplastic Anemia (SAA)Severe aplastic anemia (SAA) is a serious and rare hematologic disease that may be fatal if untreated promptly···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 142

• FDA Approves Promacta as First-Line Therapy for Aplastic Anemia

  Overview of Severe Aplastic Anemia (SAA)Severe aplastic anemia (SAA) is a serious and rare hematologic disease that may be fatal if untreated promptly···【Read More】

  Update: 2026-03-19Source: Haiou HealthViews: 145